Location History:
- Maddington, AU (2007 - 2010)
- Cambridge, MA (US) (2001 - 2012)
- Victoria, AU (2024)
Company Filing History:
11 out of 850 
1 out of 36 
1 out of 1 Years Active: 2001-2024
Title: Innovative Contributions of Samantha J. Busfield
Introduction: Samantha J. Busfield is a prominent inventor based in Maddington, Australia. With an impressive portfolio of 12 patents, she has made significant contributions to the fields of molecular biology and biochemistry. Her inventive work primarily focuses on glycoproteins and their applications in medicine.
Latest Patents: Among her latest patents are two notable inventions. The first, titled Glycoprotein VI and uses thereof, pertains to isolated nucleic acid and polypeptide molecules that encode glycoprotein VI, a key player in platelet-collagen interactions. This invention includes various elements such as antisense nucleic acid molecules, expression vectors, host cells with introduced vectors, and non-human transgenic animals. It also provides a range of isolated polypeptides, fusion polypeptides, antigenic peptides, and antibodies, along with diagnostic, screening, and therapeutic methods for utilizing these compositions.
The second patent, EGF-like nucleic acids and polypeptides and uses thereof, introduces isolated nucleic acid molecules labeled ELVIS-1, ELVIS-2, and ELVIS-3. These nucleic acids encode secreted and transmembrane proteins that demonstrate homology to epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-α). This invention also offers isolated polypeptides, fusion polypeptides, antigenic peptides, and antibodies, with applications in diagnostic and therapeutic methods, ultimately helping to modulate various cellular processes.
Career Highlights: Samantha has built her career working with esteemed institutions such as Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. Her work in these organizations has allowed her to innovate and contribute to significant advancements in the biotechnology sector.
Collaborations: Throughout her career, Samantha has collaborated with notable colleagues, including Jean-Luc Villeval and David P. Gearing. These collaborations have undoubtedly enriched her research and innovation, showcasing the power of teamwork in scientific advancements.
Conclusion: Samantha J. Busfield's contributions to the invention of innovative glycoprotein-related technologies and nucleic acid applications illustrate her vital role in advancing the field of molecular biology. Her extensive number of patents and collaborations demonstrate her commitment to scientific excellence and her potential to enhance therapeutic methods in medicine.